News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Major global markets traded flat with low volume after no new headline drivers in the past hour.
  • U.S. Treasury yields moved minimally, reflecting absence of fresh economic data or Fed commentary.
  • Dollar remained steady against major currencies amid muted risk flows.
  • Oil and gold prices showed little change as commodity markets awaited new catalysts.
  • No significant geopolitical events or policy announcements were reported in the past hour.
  • Corporate newsflow and earnings releases were quiet, leaving stocks without new directional catalysts.

Latest Articles

S&P Revises TTM Technologies Outlook to Stable After $1.1 Billion Epiq Deal

S&P Revises TTM Technologies Outlook to Stable After $1.1 Billion Epiq Deal

S&P Global Ratings downgraded its outlook on TTM Technologies to stable from positive while maintaining the company's 'BB' issuer credit rating after TTM announced a $1.1 billion acquisition of Epiq Solutions. The agency expects the purchase will be financed with debt, lifting pro forma leverage into the high-2x area when the transaction closes in …

What Underwear Should You Buy for Fall? Duluth Trading Shares First-Layer Essentials for Back to Campus and Back to Work

What Underwear Should You Buy for Fall? Duluth Trading Shares First-Layer Essentials for Back to Campus and Back to Work

Duluth Trading Co. highlights the importance of upgrading underwear as a foundational wardrobe piece for fall, focusing on comfort, moisture-wicking, and fit for both men and women. With a record $146.8 billion anticipated for back-to-school spending in 2026, Duluth encourages consumers to consider performance-driven first-layer apparel from its Bu…

Cycurion: 1-for-8 Reverse Split Backed by Stronger Fundamentals

Cycurion: 1-for-8 Reverse Split Backed by Stronger Fundamentals

Cycurion, Inc. announces a 1-for-8 reverse stock split to meet NASDAQ listing requirements, backed by significant improvements including expanded gross margins, reduced net debt by over 50%, completion of two acquisitions, and a 10-year $54.6 million contract with HHS. The company targets break-even profitability by Q2 2027 and is confident in its …

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

Revolution Medicines announced FDA approval of RASONQUE (daraxonrasib), an oral, broad-spectrum RAS inhibitor for adults with metastatic pancreatic adenocarcinoma who have received prior systemic therapy or are ineligible for multiagent therapy. The approval, based on the positive Phase 3 RASolute 302 trial results showing a 60% reduction in risk o…

Garden Grove Clarity Helps, But Melrose Still Has Work to Do

Garden Grove Clarity Helps, But Melrose Still Has Work to Do

Melrose's announcement around the Garden Grove asset removes a key overhang and should give the stock some breathing room. That said, execution on integration, cash conversion and debt reduction remains the dominant driver for returns. This trade idea sizes a tactical long with clearly defined entry, stop and target framed around the remaining exec…

KNDS Prepares to Reopen Investor Roadshow as Defense Stocks Recover

KNDS Prepares to Reopen Investor Roadshow as Defense Stocks Recover

KNDS NV is resuming investor engagement about a possible initial public offering this year after earlier plans were paused amid a downturn in defense stocks. The company is planning investor update meetings next week and is exploring a relaunch of the IPO process as soon as the second half of September, though the timeline remains subject to feedba…

Morgan Stanley Says Thai Refiners Set to Significantly Lift Dividend Payouts

Morgan Stanley Says Thai Refiners Set to Significantly Lift Dividend Payouts

Morgan Stanley projects Thai oil refiners will sharply boost shareholder distributions, noting a twofold increase has already occurred and forecasting a threefold rise in 2026. The bank links the outlook to stronger cash generation from elevated margins, reduced debt loads and moderated capital spending, while pointing to tight product markets driv…

Qifu Technology Shares Fall Sharply After Multiple Broker Downgrades

Qifu Technology Shares Fall Sharply After Multiple Broker Downgrades

Qifu Technology (NASDAQ:QFIN) fell 17.9% on Wednesday after several Wall Street analysts downgraded the stock and lowered price targets, following second-quarter results that missed estimates and third-quarter guidance that came in below consensus. Analysts pointed to industry liquidity and credit collection pressures, lower-than-expected loan volu…

EQT: Buy the Structural Gas Story at a Reasonable Price

EQT: Buy the Structural Gas Story at a Reasonable Price

EQT offers a long-term buy opportunity driven by durable demand for U.S. natural gas, a clean balance sheet, and attractive valuation metrics. With a market cap near $34.5B, a P/E around 12.5 and free cash flow of roughly $3.76B, the stock provides a disciplined way to play secular tailwinds like LNG exports, data center gas demand, and infrastruct…

Royalty Pharma: Execution Is Lifting Multiples — Trade the Re-rating

Royalty Pharma: Execution Is Lifting Multiples — Trade the Re-rating

Royalty Pharma (RPRX) has continued to execute: steady cash generation, a $500M funding deal with Teva, new hires to expand in Asia, and a quarterly dividend. The balance sheet and free cash flow ($2.98B) underpin a re-rating opportunity as the market rewards recurring royalty cash flows and growth from development-stage deals. We outline a swing t…